170 related articles for article (PubMed ID: 2659281)
1. The pathology of murine myelogenous leukemias.
Perkins AS
Curr Top Microbiol Immunol; 1989; 149():3-21. PubMed ID: 2659281
[TBL] [Abstract][Full Text] [Related]
2. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
[TBL] [Abstract][Full Text] [Related]
3. [Clinico-cytological parallels in acute myeloid leukemia in children].
Protasova AK; Maiakova SA; Tupitsyn NN; Rybina LN
Pediatriia; 1991; (11):39-43. PubMed ID: 1766738
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
5. Cytochemical diagnosis of acute myelomonocytic leukemia.
Tavassoli M; Shaklai M; Crosby WH
Am J Clin Pathol; 1979 Jul; 72(1):59-62. PubMed ID: 88177
[TBL] [Abstract][Full Text] [Related]
6. Quantitative enzyme determination in acute myeloid leukemia.
Ossenkoppele GJ; Wijermans PJ; Huijgens PC; Nauta JJ; Langenhuijsen MM
Leuk Res; 1991; 15(6):481-6. PubMed ID: 1650411
[TBL] [Abstract][Full Text] [Related]
7. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
Kaiserling E; Horny HP; Geerts ML; Schmid U
Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
[TBL] [Abstract][Full Text] [Related]
8. Monocytic leukemias.
Shaw MT
Hum Pathol; 1980 May; 11(3):215-27. PubMed ID: 6995269
[TBL] [Abstract][Full Text] [Related]
9. To the incidence of nucleoli in circulating myeloblasts of patients suffering from acute myeloblastic, promyelocytic and myelomonocytic leukemias.
Smetana K; Subrtová H; Jirásková I; Klamová H; Lemez P; Rosa L
Neoplasma; 1998; 45(5):277-81. PubMed ID: 9921915
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
[TBL] [Abstract][Full Text] [Related]
11. Phagocytosis in acute leukemia.
Glasser L
Cancer; 1980 Mar; 45(6):1365-9. PubMed ID: 6153567
[TBL] [Abstract][Full Text] [Related]
12. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
Namikawa R; Ueda R; Kyoizumi S
Blood; 1993 Oct; 82(8):2526-36. PubMed ID: 8104540
[TBL] [Abstract][Full Text] [Related]
13. Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias.
Cousar JB; Briggs RC
Leuk Res; 1990; 14(10):915-20. PubMed ID: 2259228
[TBL] [Abstract][Full Text] [Related]
14. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis.
Su WP
Semin Dermatol; 1994 Sep; 13(3):223-30. PubMed ID: 7986692
[TBL] [Abstract][Full Text] [Related]
15. The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
Davey FR; Erber WN; Gatter KC; Mason DY
Am J Clin Pathol; 1988 Jan; 89(1):76-80. PubMed ID: 3422117
[TBL] [Abstract][Full Text] [Related]
16. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.
Bijl JJ; van Oostveen JW; Walboomers JM; Brink AT; Vos W; Ossenkoppele GJ; Meijer CJ
Leukemia; 1998 Nov; 12(11):1724-32. PubMed ID: 9823947
[TBL] [Abstract][Full Text] [Related]
17. Expression of a monocyte-specific esterase isoenzyme in cases of acute myeloid leukemias.
Drexler HG; Klein M; Bhoopalam N; Menon M; Messmore HL; Gaedicke G; Minowada J
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1485-91. PubMed ID: 3868620
[TBL] [Abstract][Full Text] [Related]
18. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
[TBL] [Abstract][Full Text] [Related]
19. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
Drexler HG; Menon M; Gaedicke G; Minowada J
Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
[TBL] [Abstract][Full Text] [Related]
20. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
